Binsalamah Ziyad 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-08-20 3:57 pm Sale | 2020-08-18 | 13D | Interpace Biosciences, Inc. IDXG | Binsalamah Ziyad | 0 0.000% | -300,000 (Position Closed) | Filing |
| 2020-07-24 09:10 am Purchase | 2020-07-21 | 13D | Interpace Biosciences, Inc. IDXG | Binsalamah Ziyad | 300,000 7.430% | 300,000 (New Position) | Filing |